Log In
Print
BCIQ
Print
Print this Print this
 

Cx611

  Manage Alerts
Collapse Summary General Information
Company TiGenix N.V.
DescriptionSuspension of expanded adipose-derived allogeneic stem cells
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Stem cell
Latest Stage of DevelopmentPhase II
Standard IndicationRheumatoid arthritis (RA)
Indication DetailsTreat refractory rheumatoid arthritis (RA)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today